Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.67

-0.55

-0.42

-0.3

Details

Expected EPS

-0.4242

Actual EPS

-0.3

Surprise EPS

0.12

Surprise Percent

+29.28%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.3 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.